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Abstract
Background: Malaria transmission is highly heterogeneous in most settings, resulting in the formation of
recognizable malaria hotspots. Targeting these hotspots might represent a highly efficacious way of controlling or
eliminating malaria if the hotspots fuel malaria transmission to the wider community.
Methods/design: Hotspots of malaria will be determined based on spatial patterns in age-adjusted prevalence and
density of antibodies against malaria antigens apical membrane antigen-1 and merozoite surface protein-1. The
community effect of interventions targeted at these hotspots will be determined. The intervention will comprise
larviciding, focal screening and treatment of the human population, distribution of long-lasting insecticide-treated
nets and indoor residual spraying. The impact of the intervention will be determined inside and up to 500 m
outside the targeted hotspots by PCR-based parasite prevalence in cross-sectional surveys, malaria morbidity by
passive case detection in selected facilities and entomological monitoring of larval and adult Anopheles populations.
Discussion: This study aims to provide direct evidence for a community effect of hotspot-targeted interventions.
The trial is powered to detect large effects on malaria transmission in the context of ongoing malaria interventions.
Follow-up studies will be needed to determine the effect of individual components of the interventions and the
cost-effectiveness of a hotspot-targeted approach, where savings made by reducing the number of compounds
that need to receive interventions should outweigh the costs of hotspot-detection.
Trial registration: NCT01575613. The protocol was registered online on 20 March 2012; the first community was
randomized on 26 March 2012.
Keywords: Anopheles, elimination, epidemiology, eradication, falciparum, heterogeneity, immunology, malaria,
molecular, transmission
Background
The transmission of infectious agents is highly heteroge-
neous in space and time. For many infectious diseases, a
small number of human hosts are most frequently or
most heavily infected while the majority of a local popu-
lation is much less affected [1-4]. In malaria, this hetero-
geneity of disease transmission often results in variation
in malaria incidence within small areas [5-10]. In some
settings the non-random distribution of malaria inci-
dence between households appears to conform to the
‘20/80 rule’ [2], whereby approximately 20% of a host
population contributes 80% of the cases of an infectious or-
ganism [5,9]. The factors underlying the micro-epidemiology
of malaria are not fully understood but include variation in
distance from the nearest mosquito breeding site [5-9,11],
wind direction[12], house construction features [6,8,9,13,14],
human behavioural [7,8,13] and genetic factors [7,8,15].
Heterogeneity in malaria transmission has implications
for malaria control. Individuals who are bitten most
* Correspondence: teun.bousema@lshtm.ac.uk
†Equal contributors
1Department of Immunology & Infection; Faculty of Infectious and Tropical
Diseases, London School of Hygiene and Tropical Medicine, London, UK
2Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands
Full list of author information is available at the end of the article
TRIALS
© 2013 Bousema et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Bousema et al. Trials 2013, 14:36
http://www.trialsjournal.com/content/14/1/36
often are most likely to be infected and can amplify
transmission by infecting a large number of mosquitoes
with malaria parasites. Estimates of the basic reproduct-
ive number (R0), a central concept in infectious disease
epidemiology defined as the average number of second-
ary cases arising in a susceptible population as a result
of a single human case over the course of their infection,
are sensitive to assumptions of heterogeneous mosquito
exposure. R0 may be four times higher when heteroge-
neous mosquito exposure, as opposed to homogeneous
exposure, is considered [2,4,16].
The large influence of heterogeneous exposure on
malaria transmission also suggests that interventions tar-
geting areas of comparatively high exposure can be
highly effective. Woolhouse and colleagues suggested
that, depending on the costs of identifying hotspots of
transmission, treating the core 20% might be preferable
to non-targeted interventions on economic grounds [2].
If hotspots fuel transmission to a wider geographical re-
gion, community protection may be achieved by target-
ing those individuals that are most important for disease
transmission. This hotspot-targeted approach will be
most (cost) effective if the assumption that hotspots fuel
transmission in surrounding areas is correct – and then
only if such hotspots can be reliably detected [4]. Several
approaches to identify hotspots of malaria transmission
have been proposed in recent years. Annual incidence of
clinical malaria is a frequently used indicator of hotspots
of malaria transmission [8-10] but is affected by a differ-
ential acquisition of protective immune responses inside
and outside hotspots [17,18]. Geographical clustering of
asymptomatic parasite carriage may be a more stable in-
dicator of hotspots of transmission [10] and in areas of
moderate or low endemicity hotspots might be most
readily detected using serological markers of malaria
exposure [9,10,19-22]. In an area of moderate endem-
icity in Tanzania, serological data have been used to
identify clinically and entomologically confirmed hot-
spots of malaria transmission with 96% sensitivity and
82% specificity [9].
This manuscript describes a methodological approach
to identifying hotspots of malaria transmission and a
protocol for the evaluation of a hotspot-targeted inter-
vention. The aim of this intervention study is to deter-
mine whether the simultaneous roll-out of interventions
in hotspots of malaria transmission has a community-
wide effect that extends beyond the hotspot boundaries
and results in local reduction and possibly elimination of
malaria.
Methods/design
Study area
The study will be conducted in highland fringe localities
(1400 m to 1600 m altitude) in Rachuonyo South
District, Western Kenya (34.75 to 34.95°E, 0.41 to 0.52°S).
The predominant ethnicity in Rachuonyo is Luo. Local
residents depend upon farming, cattle and goat herding
for subsistence [23]. Compounds comprise an average of
two houses (25th to 75th percentile 1 to 3) and are distrib-
uted broadly across a rolling landscape intersected with
small streams and rivers. The main malaria vectors in the
area are Anopheles gambiae s.s., An. arabiensis, and An.
funestus. Malaria transmission is seasonal, with two peaks
in malaria cases reflecting the bimodal rainfall pattern; a
peak corresponding to the heaviest rainfall typically occurs
between March and June and there is a smaller peak be-
tween October and November each year. Most malaria is
caused by Plasmodium falciparum [23]. Community
cross-sectional surveys conducted in 2010 indicated para-
site prevalence averaging 14.8% in the general population
but varying between localities from 0% and 51.5%. School
surveys carried out in primary schools in the same year
indicated an average parasite prevalence of 25.8% in 7 to
18 year olds (minimum and maximum for individual
schools 0 to 71.4%). Insecticide-treated nets (ITNs) have
been promoted by the Ministry of Public Health and Sani-
tation for many years and distribution campaigns have
taken place through antenatal and child health clinics,
reaching net ownership for under 5s of 82.7%, as deter-
mined in surveys in 2010 (unpublished data). In addition,
community-wide mass distribution of ITNs was under-
taken by the Division of Malaria Control (DOMC) in
2011. Indoor residual spraying (IRS) with a pyrethroid was
first carried out in Rachuonyo South in mid 2008 with
financial support of the US President’s Malaria Initia-
tive. Reported house coverage with IRS in Rachuonyo
South was estimated at 70.3% in 2009 and 74.3% in 2010.
Sampling strategy to identify hotspots of transmission
We will select a 5 × 20 km (100 km2) area within which
results from recent community and school malaria surveys
suggest highly heterogeneous malaria exposure. The study
area will be divided into 400 cells of 500 × 500 m that will
be further subdivided into four sub-cells of 250 × 250 m.
All structures in the area have been geo-located using
contemporaneous high-resolution satellite data (Quick-
bird; DigitalGlobe Services, Inc., Denver, CO, USA),
which were acquired and processed using standard
digital image processing techniques (ENVI 4.8, Exelis
Visual Information Solutions, McLean, VA, USA). Pan-
sharpened colour images were then imported into a geo-
graphic information system (ArcGIS 9.2; Environmental
Systems Research Institute, Redlands, CA, USA) and all
structures digitized manually, giving a total of 8,632
structures with a median of 45 (25th to 75th percentile,
35 to 52) per 500 × 500 m cell. We aim to obtain mea-
surements from ≥50 individuals per 500 × 500 m cell,
since estimates of sero-conversion rates from fewer than
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50 observations from all age groups combined are likely to
be unreliable [9]. To maximize the discriminative power
of serological markers of exposure, we will sample indivi-
duals in predefined age strata (≤5 years; 6 to 10 years; 11
to 15 years; 16 to 25 years and >25 years). For logistical
reasons, our unit of sampling will be the compound.
To limit the chances of two selected structures belong-
ing to the same compound, an iterative sampling ap-
proach will be used that involves randomly selecting a
‘seed’ structure and then removing all closely neighbouring
structures (within 50 m) from the sample universe before
proceeding to select a second structure. This process will
be repeated until all possible ‘non-neighbouring’ struc-
tures have been selected. From the resulting list of eligible
structures a sample of 16 structures will be chosen from
each 500 × 500 m cell. To ensure maximum geographical
coverage, at least one compound will be selected from
each 250 × 250 m sub-cell, while the number of com-
pounds selected from each of the sub-cells will be
weighted by the structure density in these sub-cells.
All other structures in which people sleep and which
are associated with each selected compound will be
included. The target number of 50 observations per
500 × 500 m cell is chosen irrespective of the population
density of the cells.
Data collection and measurements to identify hotspots of
transmission
Enumeration
For planning purposes, the field area will be subdivided
into 20 blocks of 5 × 4 cells (that is, a block is 2.5 × 2
km in size). Teams will be provided with a printed over-
view map of the block they are working in (Figure 1), as
well as detailed high-resolution maps incorporating the
QuickBird satellite data for each 500 × 500 m cell. Each
team will also be provided with a handheld global posi-
tioning system (GPS) receiver (Garmin 62S; Garmin
International, Inc., Olathe, KS, USA) that has been pre-
loaded with the selected compound positions and cell
boundaries. An enumeration team, comprising one field
worker, a reporter and a local guide, will visit selected
compounds to explain the study procedures, enumerate
inhabitants, collect information on house characteristics
and inform residents that the survey team will visit later
that day. In situations where none of the structures
within a selected compound corresponds with a residen-
tial building, the selected compound will be replaced
with the nearest visible inhabited compound. The loca-
tion of this replacement compound will be recorded on
the satellite images, mapped using the GPS and recorded
on the enumeration forms.
All compounds where at least one adult (>20 years)
and one child (<15 years) are permanent residents
(defined as sleeping regularly in the structure) qualify for
enrolment. For compounds with fewer residents, repla-
cements will be made, as described. If the head of the
compound agrees to participate, the geographical coor-
dinates of the main house of the compound will be
recorded and compound and individual house codes will
be written on the doors of all sleeping structures with a
permanent marker. The names and ages of all com-
pound members will be recorded on study forms and in-
formation on compound and house characteristics,
including structure type, ITN coverage, and IRS history,
will be collected using a precoded questionnaire (Pro-
grammed in Visual Basic, Visual CE v11.0) on a personal
digital assistant (HP Ipaq 210, Windows Mobile 6.1). A
personal study identification (ID) card will be issued to
each individual, which has to be shown to the sampling
team when they visit later that same day.
The field workers will carry a checklist to record the
cumulative number of selected individuals for each age
category. The order in which compounds are visited will
be randomly selected based on a computer-generated
list. After completing a compound, the enumeration
team continues to the next compound until at least ten
compounds have been enumerated. If the checklist indi-
cates that age targets are not met at this point, they will
continue visiting compounds according to the list until
each age target is met.
Sampling
After enumeration, participating compounds will be vis-
ited by a sampling team consisting of two fieldworkers
trained in consenting, interviewing and sampling techni-
ques. Sampling teams will be provided with relevant
maps, compound lists, enumeration forms and ID cards
in advance. Compounds will be located using the names
of the compound heads and by codes marked on doors
at the point of enumeration; compound occupants will
be asked to present their ID card for formal confirm-
ation. Informed consenting will be conducted and the
name, sex, age, residency and travel history, ITN use and
sleeping times of each compound member will be
recorded. The axillary temperature of each compound
member will be measured by digital thermometer (Etos,
Zaandam, the Netherlands). For all febrile individuals
(>37.2°C axillary temperature), a rapid diagnostic test
(RDT; ParacheckW, Orchid Biomedical Systems, Goa,
India) to detect P. falciparum-specific histidine rich
protein-2 will be performed. For all individuals surveyed,
a single finger prick sample will be taken for haemoglo-
bin (Hb) measurement using a HemoCue photometer
(HemoCue 201+, Angelholm, Sweden) and three dro-
plets of blood transferred onto a filter paper (3MM
Whatman, Maidstone, UK) for serum and DNA collec-
tion. After transfer to a field laboratory, filter papers will
be dried overnight and stored in plastic bags with silica
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gel. Once a week, samples will be transported to the
Kenya Medical Research Institute (KEMRI) CDC labora-
tory in Kisumu and stored at −20°C until further proces-
sing. All individuals with an Hb ≤11 g/dl will be given
hematinics; individuals with an Hb ≤6 g/dl will be ac-
companied to a nearby health centre for further care. Fe-
brile individuals who are found to be parasitaemic by
RDT will be given artemether-lumefantrine (AL, Coar-
temW, Novartis, Switzerland); women of childbearing age
who are RDT positive will be assessed for pregnancy and
offered a pregnancy test if deemed appropriate. Febrile
children below 6 months of age and women who are
suspected or found to be pregnant or are unwilling to be
tested will be transported to the nearest health facility
for a full assessment and treatment.
Malaria parasite prevalence
A combined extraction of DNA and elution of anti-
bodies will be performed on the samples collected. Two
discs with a diameter of 2.5 mm will be cut from the
centre of a single filter paper bloodspot using a hole-
puncher and will be eluted in deep well plates with
addition of 1120 μl of a 0.5% saponin/phosphate buffered
saline solution (Sigma Aldrich, Gillingham, UK). DNA will
be extracted using the protocol described by Plowe et al.
[24]; parasites will be detected by nested PCR [25,26].
Serological markers of malaria exposure
Total immunoglobulin G (IgG) antibodies against P. falcip-
arum apical membrane antigen (AMA-1) and merozoite
surface protein 1 (MSP-119) will be detected by ELISA
Figure 1 Overview map of one block in the study area comprising 20 cells. A map of a 2 × 2.5 km section of the study area that comprises
20 500 × 500 m cells and 80 sub-cells. Cell numbers are given in black bold letters; grey crosses indicate structures; green circles with black
crosses indicate selected and numbered households. Rivers and roads are indicated in the map as given in the legend.
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using standard methodology [27,28]. Three serological
outcome measures will be used to determine spatial pat-
terns in malaria exposure: (i) the combined antibody
prevalence, that is, seropositivity for AMA-1 and MSP-119
or for either of the antigens alone; (ii) the age-adjusted
log10-transformed optical density (OD) [21,29]; (iii) the
age-dependent sero-conversion rate (SCR) for combined
AMA-1, MSP-119 antibody prevalence [21,27].
Definition of hotspots
SaTScan software [30] will be used for the detection of
spatial clustering in antibody prevalence (Bernouilli
model) and log10-transformed age-adjusted OD values
(normal probability model). Circular and elliptic win-
dows [30,31] will be used to systematically scan the
study area as a whole and segments of the study area
using a 2 × 4 km rolling window. Hotspots will be
allowed to be <1 km in radius and include <25% of the
population of each window scanned. Segments of the
study area will be scanned to improve the sensitivity of
the scan to detect local hotspots. Local hotspots may
not be detected when scanning the area as a whole, since
altitude differences in the study area result in variations
in average levels of transmission intensity. A hotspot will
be defined as an area for which there is strong evidence
(P < 0.05) that the observed prevalence or density of
combined AMA-1 and MSP-119 antimalarial antibodies
is higher than expected values. Expected values are
based on average values for the area as a whole and for
the 2 × 4 km rolling window.
Since malaria antibodies are relatively long-lived and
may indicate current as well as past malaria exposure,
parasite prevalence inside and outside hotspots of mal-
aria exposure will be determined by PCR to confirm on-
going transmission in serologically defined hotspots.
Selection of hotspots and evaluation areas
Since habitation in the study area is fairly evenly distribu-
ted, with every 500 × 500 m cell having six or more resi-
dential structures, clusters are unlikely to be isolated
geographically. To minimize the influence of neighbouring
hotspots on malaria transmission in selected intervention
or control hotspots, we will select hotspots for which
there are no other hotspots detected within 1 km in any
direction from the hotspot boundary. The hotspot-
targeted intervention will be evaluated in the area sur-
rounding the hotspot (evaluation zones). The evaluation
zone will comprise the area surrounding the hotspot up to
500 m from the hotspot boundary in each direction.
Design of the intervention
Intervention clusters
Four interventions will be rolled out in the period pre-
ceding the long rainy season: larviciding, focal screening
and treatment (FSAT), long-lasting insecticide-treated
nets (LLIN) distribution and IRS. The details of inter-
ventions, and their timing, have been agreed upon in
collaboration with the DOMC of the Kenyan Ministry of
Public Health and Sanitation (MOPHS). Ten per cent of
households will be visited 1 to 2 weeks after the inter-
vention to assess any short-term side effects of the FSAT,
LLINs and IRS. This sampling strategy was not based on
sample size calculations but on logistical feasibility; few
side effects were expected.
Larviciding
All permanent aquatic mosquito habitats in intervention
hotspots will be mapped using handheld GPS receivers
during the dry season. In the period preceding the long
rainy season (April), and throughout the long rainy sea-
son (until September) all stagnant water bodies (perman-
ent and temporary) inside these hotspots will be treated
on a weekly basis with water-dispersible granule formu-
lations of the commercial strains of Bacillus thuringien-
sis var. israelensis (Bti), VectoBacW, which will be
provided by Valent BioSciences Corp., Libertyville, IL.
Larviciding will be carried out using previously pub-
lished protocols [32]; the entire hotspot area will be
examined for water bodies on a weekly basis, all of
which will be included in the intervention. Spot-checks
for surviving Anopheline larvae and pupae will be made
on a weekly basis.
Focal screen and treatment (FSAT)
All compounds in hotspots will be visited and the
temperature of each individual will be determined. All
individuals aged 6 months to 15 years regardless of
temperature and all older individuals who are febrile (tym-
panic temperature ≥37.5°C) will be tested for malaria
parasites using HRP-2 and pLDH based RDT (First
ResponseW, Premier Medical Corporation Ltd., Kachigam,
India). If one or more individuals are found to be RDT
positive the entire compound will receive a curative dose
of AL with the exception of pregnant women and children
below 6 months of age. Because of the different times at
which treatment is initiated, one treatment dose for three
consecutive days will be supervised by the field worker
(day 1) or community health workers (days 2 and 3). Each
observed dose will be given with fatty food (>1.5 g fat) to
facilitate absorption. The second daily dose will be taken
without direct supervision but advice on taking the treat-
ment with food will be given. Information on any immedi-
ate side effects of the AL will be recorded by the
community health workers at each visit; all empty blister
packs will be collected by community health workers after
treatment has been completed to monitor adherence.
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Long-lasting insecticide-treated nets
All compounds in hotspots will receive one LLIN per
two house members according to MOPHS guidelines.
LLINs (PermanetW 3.0) were donated by Vestergaard
Frandsen (Hanoi, Vietnam). House members will be
given leaflets on proper use and maintenance of nets
and study personnel will assist in hanging and demon-
strate correct use of the LLINs within houses. Usage and
retention of study nets will be assessed by questionnaire
six weeks after distribution and any missing or badly
torn nets will be replaced within two months after
distribution.
Indoor residual spraying
Routine annual IRS with lambda cyhalothrin (ICON)
will be undertaken in all structures where people are
sleeping. The IRS campaigns are jointly funded by the
Government of Kenya and the US President’s Malaria
Initiative, and implemented by the Research Triangle In-
stitute (RTI) with the MOPHS, DOMC and District
Health Management Teams. For this study IRS will fol-
low MOPHS protocols with more intense mobilization,
repeated visits and implementation prior to the start of
the malaria transmission season (March to April) in
intervention hotspots.
Control clusters
Control clusters will receive the routine malaria control
measures, which for 2012 will be the annual IRS
programme as detailed and continued case management
at health facilities. The IRS is scheduled to take place in
April to May 2012. No LLIN distribution campaigns are
planned for 2012.
Design of the randomized evaluation
Sensitization and recruitment
Prior to the implementation of the interventions, meet-
ings with district administrative and health representa-
tives in the selected areas will be organized. Community
meetings will be held with local chiefs, community
elders and opinion leaders, school representatives and
church leaders. All compounds in the selected interven-
tion areas will be visited prior to the intervention; the
procedures of the interventions and evaluation proce-
dures will be explained to all compound members
present. Identification cards will be distributed that will
be used for identification purposes during compound
visits and for identification of compound members who
visit health facilities in the area.
Randomization
Hotspots with their surrounding evaluation areas will be
randomly assigned to the intervention or control arm. This
will be done by simple randomization; no stratification by
parasite prevalence or altitude will be undertaken. Clusters
will be ordered according to their geographical location,
from northwest to southeast. Clusters will be entered in
Microsoft Excel 2010 in this geographical order; the same
programme will be used to generate random numbers for
each of the clusters. Fifty percent of the clusters with the
lowest random numbers will be assigned to the interven-
tion arm; 50% with the highest random numbers to the
control arm.
Hypotheses and outcomes
Hypotheses
1. Hotspot-targeted interventions combining
larviciding, LLINs, IRS and FSAT will reduce malaria
transmission inside and outside hotspots of malaria
transmission.
2. The community effect of hotspot-targeted
interventions, defined as the impact on parasite
prevalence in the evaluation zone surrounding the
hotspot, is a function of distance from the hotspot
boundary.
Primary and secondary outcome measures
The primary outcome measure is parasite prevalence by
PCR in the evaluation zone surrounding malaria hot-
spots in intervention and control clusters.
Secondary outcome measures are:
1. Parasite prevalence by PCR in the evaluation zone
surrounding malaria hotspots in relation to distance
to the boundary of hotspots in intervention and
control clusters.
2. Indoor and outdoor Anopheles mosquito densities
inside and outside hotspots of malaria transmission
in intervention and control clusters.
3. The presence of Anopheles larvae in mosquito
breeding sites in malaria hotspots in intervention and
control clusters.
4. The number of malaria cases reporting at health
facilities, coming from intervention and control
clusters.
5. Reported side effects and coverage of FSAT, LLINs
and IRS.
Evaluation
Cross-sectional surveys
Three cross-sectional surveys will be conducted: at base-
line prior to the interventions, during the peak transmis-
sion season, and at the end of the peak transmission
season. For each cross-sectional survey, 25 compounds
that are located inside hotspots, 25 compounds that are
located <250 m from the hotspot boundary and 25
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compounds that are located 250 to 500 m from the hot-
spot boundary will be randomly selected. This strategy is
expected to give ≥100 individual observations from each
of these three areas. To minimize confounding by neigh-
bouring hotspots, an exclusion buffer will be incorporated
in the selection of compounds, ensuring a minimum dis-
tance of ≥500 m from neighbouring hotspots.
Study teams will visit selected compounds and, subject
to obtaining informed consent, collect information from
inhabitants of all houses that belong to that compound
using personal digital assistants (PDAs). For individuals
older than 6 months, tympanic temperature will be mea-
sured and a finger prick blood sample (~300 μl) will be col-
lected for assessment of haemoglobin concentration using
Copack colour scales (COPACK GmbH, Oststeinbek,
Germany) and for collection of nucleic acids and serum on
Whatman 3MM filter paper (Maidstone, UK). Whole
blood will be collected in BD K2EDTA microcontainers
(BD Becton, Dickinson and Company, Oxford, UK) in
selected clusters for more detailed molecular analyses. A
RDT will be used to determine malaria infection for all fe-
brile individuals. Those with a positive RDT will receive
AL or will be referred to a health centre for further care.
Passive case detection
A passive case detection system will be introduced in
government and mission health facilities to monitor
individuals presenting with malaria. Facilities will be
selected to cover intervention and control clusters. For
this, the catchment areas of health facilities in the area
have been determined. Individuals from intervention
and control clusters will be asked to present a household
card whenever visiting a health facility. This household
card will be linked to geo-located compounds. For indi-
viduals who present without a household card, other in-
formation that allows geo-location will be collected,
such as nearest school. Tympanic temperature will be
measured, and an RDT used to determine parasite car-
riage for each individual with measured or reported
fever.
Entomological monitoring
In a subset of the control and intervention clusters, larval
and adult mosquito abundance will be monitored. Within
each hotspot, a random selection of 15 water bodies along
a randomly selected transect will be mapped and the pres-
ence or absence of early and late stage Anopheline larvae
and pupae will be assessed using a 250 ml mosquito dip-
per. Five dips will be made in sites smaller than 5 m2; ten
dips in sites larger than 5 m2. This will be carried out at
two-weekly intervals. Adult collections of Anopheline will
be carried out at the same time in 36 randomly selected
houses in each cluster selected in cross-sectional surveys.
Twelve of these houses will be selected within the
hotspots, of which four will be sampled by pyrethrum
spray catch (PSC), four for indoor light-trap collections
and four for outdoor light-trap collections. Outside the
hotspot 24 houses will be randomly selected of which
eight will be sampled by PSC, eight for indoor and eight
for outdoor light traps.
Pyrethrum spray catching will be carried out indoors
according to standard WHO protocols [33]. CDC mini-
ature light traps (Model 512; John W. Hock Company,
Gainesville, FL, USA) will be used following previously
published procedures to sample mosquitoes indoors [34]
and outdoors [35]. The effective range of CDC light
traps for outdoor mosquito sampling has been estimated
as 5 m [36]. Accordingly, outdoor sampling will take
place 20 m from selected houses to prevent inhabitants
acting as unshielded bait. All traps will be set at 1830
hours and collected at 0630 hours. A collection bottle ro-
tator (Model 1512, John W. Hock Company, Gainesville,
FL, US) will be fitted to eight randomly selected light traps
set indoors and outdoors within and outside the hotspot;
this allows collection cups to rotate every two hours to es-
timate vector abundance at intervals throughout the night.
Vector abundance, parity rates and the proportion of
Anopheline females unfed, fed, gravid, and infected will be
determined for each species [37] and compared between
the two study arms.
Statistical considerations
Sample size
All available malaria simulation models indicate that
malaria transmission in the area surrounding interven-
tion hotspots will decrease considerably because malaria
transmission is effectively interrupted in those com-
pounds that seed transmission to a larger geographical
area [2,16,38]. However, there are no published studies
that quantify the impact of hotspot-targeted interven-
tions. We estimated the predicted impact of targeted
interventions in our study area using one of the leading
individual-based simulation models [38], using human,
entomological and parasitological characteristics collected
at our sites in Kenya. We modelled three scenarios in situa-
tions with a pre-intervention parasite prevalence in the
human population of 10 to 20%: (i) no additional interven-
tions; (ii) targeted distribution of LLINs, reaching 90% of
the population in hotspots and (iii) targeted LLINs and tar-
geted effective IRS reaching 90% of the population in hot-
spots (Figure 2). The impact of larviciding is currently
insufficiently described to be included in the model [38].
Our simulations show that targeted interventions can
interrupt transmission completely, both inside and out-
side hotspots of malaria transmission, reducing overall
parasite prevalence to <5%, in a manner that appears
sustainable in the following years (see Figure 2). These
predictions have to be interpreted with caution, since (i)
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the simulation model has not been prospectively tested;
(ii) there is no published evidence that quantifies the im-
pact of hotspot-targeted interventions on transmission in-
tensity in the wider community; and (iii) the intensity of
transmission will be highly variable between hotspots in
our study area. There is insufficient evidence on which to
base power calculations for a cluster-randomized trial;
however, these simulations can give an indication of the
size of the effect of the planned interventions. The pri-
mary outcome measure is parasite prevalence in the evalu-
ation zone. A previous study on the community benefits
of ITNs in Asembo, Western Kenya, indicated that an in-
direct beneficial effect on malaria transmission is most
pronounced within 500 m of the intervention area [39].
We used this finding to define our evaluation zone sur-
rounding the hotspots. Assuming a sample of 200 ran-
domly selected individuals in the evaluation zone of each
cluster, a coefficient of variation of true proportions be-
tween clusters within each group (k) of 0.4 and mean
parasite prevalence of 15% and ≤5% in the control and
intervention clusters respectively, would require five clus-
ters per study arm for 80% power and 5% significance
level [40]. This power calculation is based on a compari-
son between arms and the assumption that parasite preva-
lence will remain unaltered in the control arm.
To estimate the impact of the interventions on the hot-
spots themselves a sample size of 100 individuals in each
of five clusters (hotspots) per study arm, will be required
to detect a similar difference between intervention and
control clusters (≤5% versus 15% mean prevalence) , as-
suming k = 0.5, 80% power and 5% significance.
The entomologic sampling approach was based on
previous data from PSC studies carried out by the pro-
ject where the mean number of female Anophelines
caught per house was 0.36. To detect an 80% reduction
in mean number of female Anophelines caught by PSC
in intervention houses compared with control houses at
80% power and a significance level of 5%, 213 houses
would have to be sampled in each arm. Data from light-
trap studies carried out to date have shown a mean of
1.12 female Anophelines caught indoors per trap per
night and so to detect an 80% reduction in mean num-
ber of female Anophelines compared with control houses
at 80% power and a 5% significance level, 81 traps would
have to be set in each arm per month.
Data analysis
Statistical analyses will be performed in Stata version 12
(StataCorp LP, College Station, TX, USA). The primary
analysis will be based on intention to treat whereby all
evaluation areas are included in the analysis, regardless
of the level of coverage. The main outcome measure,
parasite prevalence, will be analyzed as binary variable.
For the primary study outcome, we will compare para-
site prevalence in the evaluation zones of intervention
and control clusters using multilevel mixed-effects logis-
tic regression to account for clustering per compound
and random effects to account for differences between
study clusters [41]. For secondary study outcomes, we
will relate parasite prevalence to distance to the hotspot
boundary in meters and in bins of 100 m; this analysis
will be done for each of the clusters separately by general-
ized estimating equations (GEE), adjusting for correlations
between observations from the same compound. Indoor
and outdoor Anopheles densities will be compared between
Figure 2 Simulation of intervention outcome. The figure presents
a simulation of hotspot-targeted interventions in areas with a
baseline parasite prevalence of 10% or 20%. ITN coverage is
assumed to be 41% across all age groups (83% in under-fives).
Plotted is smoothed parasite prevalence in the total population as a
function of time in years since the start of the intervention. No
interventions (solid black line), hotspot-targeted increase in LLIN
coverage to reach 90% effective coverage in hotspots (dashed grey
line) and hotspot-targeted increase in LLIN coverage to reach 90%
effective coverage in hotspots in combination with targeted IRS
reaching 90% of households in hotspots (dashed black line).
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study arms using GEE models and Poisson or negative bi-
nomial distributions [42]. The proportion of productive
breeding sites will be compared between intervention and
control hotspots by GEE models, adjusting for correlations
between observations from the same clusters.
Ethics considerations
Ethics approval
The study proposal received ethics approval from the
Scientific Steering Committee (SSC), the ethical review
committee (ERC) of the KEMRI Nairobi (proposal num-
bers SSC 2163, 2181 and 1589), the London School of
Hygiene & Tropical Medicine ethics committee (#6111),
and from Centers for Disease Control and Prevention
(with exempt status).
Informed consent
Indoor residual spraying is to be conducted as part of
the routine district-wide malaria control programme.
Consent will be obtained orally at the compound by
community health workers and spray operators recruited
by MOPHS, as is consistent with their operating proce-
dures. Ahead of targeted distribution of LLINs, informed,
written consent will be sought at the house level from the
head of the household or representative in the presence of
an independent witness. Larviciding will be done after
consulting with and receiving approval from the DOMC,
the Kenyan Pest Control Product Board (PCPB), the dis-
trict administrative, fisheries and health teams and after
community meetings. Oral consent will be sought from
owners of or persons responsible for any privately owned
permanent breeding sites in the intervention areas (for ex-
ample, fish ponds). Since most mosquito breeding sites
are not restricted to particular households, consent at
household level is not practical and approval from the
community, DOMC and PCPB is considered adequate.
Before FSAT and cross-sectional surveys, informed
written consent will be sought from all individuals and,
if appropriate, their parents or guardians. If the signatory
is not literate, a thumbprint will be obtained and con-
firmed by an independent witness. Assent forms will be
signed by children between the ages of 13 and 17 years
and by their parents or guardians. Each assent form will
be accompanied by a consent form signed by the parent
or guardian. All consent and assent forms will be coun-
tersigned by the staff member obtaining consent and a
copy will be left at the household.
Trial oversight
Ethical and safety aspects of the study are overseen by
an independent monitor. No data safety and monitoring
board (DSMB) will be installed. Indoor residual spraying
and LLINs form part of routine malaria control in Kenya
and will be undertaken in collaboration with the DOMC
and the district public health teams. Larviciding with Bti
has been undertaken previously in neighbouring districts
and has previously been shown to pose no health risk
[43]. The proposed form of FSAT, where household
members of parasite carriers are treated regardless of
their parasite status by microscopy, is not part of the
current malaria strategy of the Kenyan DOMC, although
screening and treatment of asymptomatic parasite car-
riers is recommended [44]. Our FSAT approach is based
on the assumption of a high proportion of submicro-
scopic infections among asymptomatic individuals [45],
especially among household members of individuals with
patent parasitaemia [46]. The drug used throughout the
study, AL, is the first line antimalarial treatment in most
of East Africa, including Kenya.
Discussion
Targeting interventions to hotspots of malaria transmis-
sion is frequently mentioned as a cost-effective approach
for malaria control and elimination [2,4,5,47], although
direct evidence for a community effect of hotspot-targeted
interventions is currently unavailable. The present study
aims to determine this effect in a cluster-randomized
intervention trial.
Valuable information on how to quantify community
effects of malaria control interventions comes from trials
with ITNs [48]. Mortality rates [49], incidence of severe
malaria [50], incidence of uncomplicated malaria [39,50],
anaemia [39] and high-density parasitaemia [39] have
been shown to be reduced in compounds without ITNs
that were in close proximity of compounds with ITNs.
Hawley and colleagues found that individuals living in
control villages within 300 m of ITN villages in Kenya
experienced a level of protection similar to that experi-
enced by individuals living in ITN villages and that this
was plausibly due to area-wide effects on vector densities
and sporozoite-positive mosquitoes [39]. Despite similar-
ities, hotspot-targeted interventions may differ consider-
ably from untargeted ITN campaigns in their community
impact. Mathematical simulation models suggest that the
impact of hotspot-targeted interventions may be much
larger than that of community-wide ITN distributions and
may lead to local malaria elimination [4]. In line with this,
our trial is powered to detect large effects on malaria
transmission. However, two of the major assumptions
underlying the optimistic model outcomes are incom-
pletely understood. Firstly, the stability of hotspots is cen-
tral to ensure sustainable community effects. Hotspots of
(asymptomatic) parasite carriage are generally assumed to
be stable [4,10]. However, a report that wind direction in
relation to breeding site location may be a key element in
determining the location of hotspots [12], suggests that
local environmental factors may also influence the spatial
stability of hotspots. We believe that our approach to
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define hotspots serologically may be less susceptible to
(short-term) variations in wind direction or other eco-
logical factors, since it effectively bases hotspot-detection
on immunological markers of cumulative malaria expos-
ure [27]. Secondly, a community effect of hotspot-targeted
interventions strongly depends on mosquito mixing pat-
terns. Mosquito mixing patterns are unlikely to be homo-
geneous. Reported site-fidelity where mosquitoes are
likely to return to the same compounds [51,52] remains to
be confirmed but could considerably reduce the com-
munity effect of hotspot-targeted interventions. The
most informative measure of mixing patterns may be
an approach where parasite populations are tracked in
human populations, inside and outside hotspots of mal-
aria transmission.
Research on the impact of community interventions
where ‘herd coverage’ is required to ensure effectiveness
raises a number of practical issues. Similar to mass drug
administration campaigns, high community coverage
[53,54] is required in our study to reduce R0 to values
below 1. Our intervention is further challenged by a de-
pendence on community participation in control measures
that are only rolled out in a selected proportion of this
community. Gaining community trust is essential to the
study’s success and we expect good participation rates after
our lengthy sensitization process and strong involvement
of community leaders and local workers in all aspects of
the study preparation, intervention and evaluation.
Even with excellent participation rates, the nature of our
intervention will remain susceptible to contamination
from neighbouring hotspots. An ideal study setting would
comprise a large number of geographically isolated clus-
ters, each being an independent focus of malaria transmis-
sion, with clearly defined hotspots within these clusters
[4]. Our real-life setting falls short of this ideal scenario.
The continuous inhabitation in the area makes it unlikely
that clusters are geographically isolated. We aim to
minimize contamination from non-targeted malaria hot-
spots by incorporating an exclusion zone in our selection
of eligible hotspots and in the selection of compounds in
the evaluation phase. We nevertheless expect that there
will be residual contamination that will be reflected in a
spatial component in the effect of hotspot-targeted inter-
ventions: we expect the level of contamination to be high-
est in areas furthest away from the targeted hotspot and
nearest to untargeted hotspots. Similarly, the effect of the
intervention within the targeted hotspots may be largest
in those compounds that are most remote from the near-
est untargeted compound. Mathematical simulation models
that incorporate heterogeneous malaria exposure [16,23,38]
are expected to be valuable as an integral part of the evalu-
ation of our intervention to assess the plausibility that a
change in transmission intensity can be attributed to the
intervention.
The current study is not designed to determine the ef-
fect of individual interventions. While simulations sug-
gest that targeted interventions with LLINs and IRS will
be sufficient to eliminate malaria locally [4], we chose a
relatively comprehensive package of malaria control
measures incorporating a wide variety of available inter-
ventions, targeting both the mosquito vector and the
malaria parasite in humans. If findings from the current
study prove promising, a next step will be to determine
the optimum package of tools for hotspot-targeted inter-
ventions across a range of settings. This package will dif-
fer between different settings. Larviciding, for example,
will be most beneficial in settings where breeding sites
are discrete and well-defined [55-57] while the effects of
IRS and ITNs will be affected by insecticide resistance,
amongst other factors [48]. Importantly, follow-up stud-
ies should determine the cost-effectiveness of the hot-
spot approach to assess whether savings in the number
of compounds that need to be targeted for conventional
vector control in the absence of hotspot treatment out-
weigh the costs for hotspot-detection and coordination
of hotspot interventions.
Trial status
The trial was actively recruiting participants at the time
that the protocol was submitted for publication.
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